Flexible & Customized Development Services That Streamline the Path From Concept to Commercialization
At Adare Pharma Solutions, our goal is to provide peace of mind by leveraging decades of expertise gained from working in the contract drug development and manufacturing (CDMO) space. Our facilities are cGMP certified, FDA inspected and large enough to accommodate commercial-scale projects.
Adare creates a seamless transition at each stage of drug product development and manufacturing. In addition to our highly experienced team, we offer a number of drug development technologies that facilitate the commercialization of safe pharmaceutical products.
We deliver a comprehensive suite of services that are built to guide you from proof of concept to commercialization. Our integrated service teams are equipped with experienced, trusted leaders from the top pharmaceutical companies. From drug development to scale-up through packaging, we are ready to support you with efficiency in every part of your drug product development.
Our Product Development team includes specialists in technology innovation, formulation, analytical method development and technical services. We have helped numerous customers like you optimize processes, develop formulations, manage their supply chains, and launch their products.
Capabilities
- Pre-formulation
- Formulation development
- Support including physical characterization
- Analytical Method Development & Validation
- IMPD Manufacture and QP release
- Tech Transfer
- ICH stability programs at all conditions
- Efficient product development pathways for NCEs, ANDA, 505(b)(2), IND/NDAs, and novel delivery systems
- Preclinical to clinical to commercial capability
- IVIVC-based modified release dosage form development
Adare has been recognized as a winner of the 2025 Outsourced Pharma CDMO Leadership Awards in the Small Molecule Dosage Form – Global category. The CDMO Leadership Awards recognizes the best contract development and manufacturing organizations across global and regional categories. This achievement reflects our ongoing commitment to advancing innovation, upholding the highest standards of quality, and consistently delivering excellence in pharmaceutical development.
For more information on our Product Development capabilities, please refer to the related resources in the sidebar and speak with one of our development experts today.
Speak With An Expert
Nathan Dormer
Director, Drug Product Development
Nathan Dormer, Ph.D., is the Director of Drug Product Development at Adare Pharma Solutions and is responsible for pharmaceutical development activities at Adare’s Lenexa, KS and Philadelphia, PA facilities, where he supports a team of formulation scientists and analysts. He is a pharmaceutical scientist and bioengineer by training, with more than 16 years of experience developing microsphere-based solid oral and parenteral/implantable dosage forms in academic, innovator, and CDMO settings. Dr. Dormer earned his B.S. in Chemical Engineering and his Ph.D. (w/Honors) in Bioengineering from The University of Kansas while receiving NIH-sponsored Pharmaceutical Biotech Training.